Skip to main content
SBFM logo

SBFM · Sunshine Biopharma Inc. · Analyst Estimates

Track SBFM — free
$0.43 -0.24 (-36.08%) At close · Oct 5
Market Cap
$3.27M
Shares
3.88M
Volume · Oct 5 2.13M Avg daily vol (3M) 520.85K

Analyst Estimates

Compare analyst forecasts for Sunshine Biopharma Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 15:09 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.95
-1.95
-1.95
—
-6.3
-6.3
-6.3
-6.3
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
36752450
36752450
36752450
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.4
-0.4
-0.4
—
0.2
0.2
0.2
0.2
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
45000000
45000000
45000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.17
-0.17
-0.17
—
-0.2
-0.2
-0.2
-0.2
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
9600000
9600000
9600000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.29
-0.29
-0.29
—
-1.3
-1.3
-1.3
-1.3
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
9800000
9800000
9800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —
Key facts CIK 1402328 CUSIP 867781809 Visit website Investor relations